Consolidated Condensed Statements of Cash Flows (Unaudited) - USD ($) $ in Millions	9 Months Ended
	Jul. 31, 2024	Jul. 31, 2023
Cash flows from operating activities:
Net earnings	$ 1,869	$ 2,289
Adjustments to reconcile net earnings to net cash provided by operating activities:
Depreciation and amortization	622	638
Stock-based compensation expense	367	353
Restructuring and other charges	180	416
Deferred taxes on earnings	69	(774)
Other, net	(24)	(61)
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(447)	180
Inventory	(953)	364
Accounts payable	1,442	(1,133)
Net investment in leases from integrated financing	(123)	(82)
Taxes on earnings	(89)	354
Restructuring and other	(204)	(244)
Other assets and liabilities	(583)	(704)
Net cash provided by operating activities	2,126	1,596
Cash flows from investing activities:
Investment in property, plant and equipment, net	(439)	(459)
Purchases of available-for-sale securities and other investments	0	(6)
Maturities and sales of available-for-sale securities and other investments	0	18
Collateral posted for derivative instruments	(60)	(118)
Payment made in connection with business acquisitions, net of cash acquired	(15)	(5)
Net cash used in investing activities	(514)	(570)
Cash flows from financing activities:
Proceeds from short-term borrowings with original maturities less than 90 days, net	0	190
Proceeds from debt, net of issuance costs	266	177
Payment of debt and associated costs	(153)	(1,654)
Stock-based award activities and others	(67)	(86)
Repurchase of common stock	(1,200)	(100)
Cash dividends paid	(812)	(777)
Collateral returned for derivative instruments	0	(200)
Settlement of cash flow hedges	0	(3)
Net cash used in financing activities	(1,966)	(2,453)
Decrease in cash, cash equivalents and restricted cash	(354)	(1,427)
Cash, cash equivalents and restricted cash at beginning of period	3,232	3,145
Cash, cash equivalents and restricted cash at end of period	$ 2,878	$ 1,718